DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1160541
Title:
The Role of Mesothelial Omentin in Ovarian Cancer Progression
Descriptive Note:
[Technical Report, Final Report]
Corporate Author:
UNIVERSITY OF SOUTH FLORIDA TAMPA
Report Date:
2021-08-01
Pagination or Media Count:
60
Abstract:
We hypothesize that omentin ITLN1 suppresses ovarian cancer progression by sequestering lactotransferrin LTF from its receptor LRP1 on the ovarian cancer cells and adipocytes, and that lactotransferrin promotes ovarian cancer cells motility and growth. The most significant finding in this research period are 1 exogenous omentin suppresses ovarian cancer cells motility and invasive potential, 2 matrix etalloproteinase-1 MMP1 mediated the effects of omentin on suppressing ovarian cancer cells motility and invasive potential, 3 ITLN1 abrogates LTFs effects on ovarian cancer cells motility and invasive potential 4 omentin suppressed ovarian cancer growth by enhancing insulin-dependent glucose inadipocytes via facilitative glucose transporter GLUT4SLC2A4, and 5 exogenous omentin suppressed ovarian cancer progression in vivo.
Distribution Statement:
[A, Approved For Public Release]